Rafferty Asset Management, LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 872 filers reported holding BAXTER INTL INC in Q2 2016. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$1,994,031
-10.6%
52,836
+7.9%
0.01%
-7.7%
Q2 2023$2,230,116
+21.8%
48,949
+8.4%
0.01%
+8.3%
Q1 2023$1,831,325
-17.2%
45,151
+4.0%
0.01%
-36.8%
Q4 2022$2,212,710
+52.3%
43,412
+61.0%
0.02%
+26.7%
Q3 2022$1,453,000
+85.1%
26,970
+120.8%
0.02%
+114.3%
Q2 2022$785,000
-33.9%
12,217
-20.2%
0.01%0.0%
Q1 2022$1,187,000
-17.9%
15,305
-9.1%
0.01%
-12.5%
Q4 2021$1,445,000
+12.7%
16,830
+5.6%
0.01%
-11.1%
Q3 2021$1,282,000
+53.0%
15,939
+53.1%
0.01%
+80.0%
Q2 2021$838,000
+4.2%
10,409
+9.2%
0.01%0.0%
Q1 2021$804,000
+18.9%
9,531
+13.2%
0.01%
-28.6%
Q4 2020$676,000
-8.0%
8,419
-7.8%
0.01%
-22.2%
Q3 2020$735,000
-25.5%
9,136
-20.2%
0.01%
-35.7%
Q2 2020$986,000
+212.0%
11,446
+193.7%
0.01%
+7.7%
Q1 2020$316,000
-72.5%
3,897
-71.6%
0.01%
-27.8%
Q4 2019$1,149,000
+134.5%
13,746
+82.6%
0.02%
+157.1%
Q1 2018$490,000
-6.3%
7,528
-7.0%
0.01%
-22.2%
Q4 2017$523,000
+13.7%
8,095
+10.3%
0.01%
-10.0%
Q3 2017$460,000
-10.5%
7,336
-13.5%
0.01%
-33.3%
Q2 2017$514,000
+7.1%
8,482
-8.3%
0.02%
+36.4%
Q1 2017$480,000
+10.1%
9,251
-6.0%
0.01%
-45.0%
Q4 2016$436,000
-19.9%
9,843
-14.0%
0.02%0.0%
Q3 2016$544,000
-7.6%
11,439
-12.2%
0.02%
-50.0%
Q2 2016$589,000
-18.9%
13,022
-26.3%
0.04%
+2.6%
Q1 2016$726,000
-9.5%
17,675
-15.9%
0.04%
-59.4%
Q4 2015$802,000
-5.1%
21,020
-18.3%
0.10%
+43.3%
Q3 2015$845,00025,7250.07%
Other shareholders
BAXTER INTL INC shareholders Q2 2016
NameSharesValueWeighting ↓
GENERATION INVESTMENT MANAGEMENT LLP 21,171,371$1,817,350,0007.47%
Soditic Asset Management LLP 147,620$12,672,0006.53%
NUANCE INVESTMENTS, LLC 4,084,218$350,589,0006.17%
PRAGMA GESTAO DE PATRIMONIO LTD 145,000$12,4475.96%
Veritas Asset Management LLP 12,222,261$1,049,159,0005.89%
Pavadi Capital LLC 72,782$6,248,0004.74%
Sonen Capital LLC 48,907$4,198,0004.06%
Glenview Capital Management 2,182,422$187,339,0003.99%
Dash Acquisitions Inc. 103,963$8,924,0003.87%
Avidity Partners Management LP 1,765,000$151,508,0003.21%
View complete list of BAXTER INTL INC shareholders